ACE cardiovascular protection: EUROPA versus HOPE.
Christopher J
CJ
Boos
Matthew
M
Dawes
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D015337:Multicenter Studies as Topic / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome; D006113:United Kingdom
D000806:Angiotensin-Converting Enzyme Inhibitors